This population-based cohort study used tumor specimen blocks from a subset of women aged 66 to 75 years with newly diagnosed nonmetastatic, estrogen receptor–positive invasive breast cancer from January 1, 1993, to December 31, 2007. This evidence concerns the gene ESR1 and neoplasm.